1 Stock That Is The Power Behind Nuclear Revival?
Cameco isn’t just a miner. It’s the world’s largest publicly traded uranium producer, but its reach extends far beyond extraction.
The company refines uranium, manufactures reactor fuel rods, and even owns 49% of Westinghouse Electric, one of the few firms that designs and builds nuclear reactors. This level of integration is rare in the commodity world,
» Read more about: 1 Stock That Is The Power Behind Nuclear Revival? »
Read More
Is This The #1 Semi Stock To Buy Now?
AI stocks have been on fire in 2025. After Oracle and other hyperscalers revealed record-breaking capital expenditures, most semiconductor names raced back toward all-time highs. Yet one company that sits at the very heart of chip production has been noticeably absent from the party, ASML.
Despite that enviable position, the stock hasn’t kept pace with the AI rally.
» Read more about: Is This The #1 Semi Stock To Buy Now? »
Read More
Can This Fintech Darling Bounce Back?
Chime Financial is one of the most talked-about fintech players, but it has had a rollercoaster ride since its June IPO. The stock ran up to $43 on its first day of trading, riding a wave of excitement around digital banking. Fast-forward to today, and shares have been clipped by almost 50%.
So the big question is can Chime regain momentum and reward patient investors?
» Read more about: Can This Fintech Darling Bounce Back? »
Read More
Is This Healthcare Stock Set To Rally?
Eli Lilly has been a frustrating hold so far this year. Shares are slightly down year to date, a rare stumble for a company that has delivered nearly 5x returns over the past five years.
For a stock that’s become a poster child of the weight-loss and diabetes boom, the slowdown in momentum has left investors wondering if the story has run its course.
» Read more about: Is This Healthcare Stock Set To Rally? »
Read More
Ken Griffin’s Big Trim in Palantir
In the second quarter of 2025, Ken Griffin’s Citadel Advisors sharply reduced its holding in Palantir Technologies, selling nearly half of its position.
The move raised about $75 million in cash and followed a familiar pattern for Griffin, who has been building and trimming his Palantir stake in waves since 2021.
This latest sale has investors wondering: why would one of Wall Street’s most sophisticated fund managers cut exposure to a stock riding the artificial intelligence boom?
» Read more about: Ken Griffin’s Big Trim in Palantir »
Read MoreThe Burst
Why Warren Buffett Loaded Up on Heico
Berkshire Hathaway quietly raised its stake in Heico by over 11% last quarter, bringing its total position to about 1.3 million shares. That move turned heads because Heico isn’t a typical Buffett pick. It’s not cheap by traditional value metrics, and it doesn’t sell iconic brands like Coca-Cola or Geico.
So why did Berkshire,
» Read more about: Why Warren Buffett Loaded Up on Heico »
Read MoreThe Spotlight
1 Stock to Own for the Next Decade
Every once in a while, a company comes along that feels like the rare exception, a business so well-positioned, diversified, and forward-looking that it could anchor a portfolio for years.
Broadcom is one of those companies and it might be the single best position to hold for the foreseeable future.
Key Points
-
Broadcom combines cyclical chip sales with high-margin recurring software revenue from acquisitions like CA,
» Read more about: 1 Stock to Own for the Next Decade »
Read MoreThe Daily
A Wall Street Analyst Who Correctly Predicted the Stock Market Collapse in 2022 Has a New Price Target for the S&P 500 Index — and It May Surprise You
Every year, market strategists at Wall Street’s top banks try to estimate where the S&P 500 will be in a year.
Trying to predict where the broader benchmark S&P 500 index will land in 12 months is one of the toughest jobs on Wall Street. Nobody can predict the future,